All-Spectrum Transradial Approach: Safer than Femoral

Original Title: Radial vs femoral access for coronary interventions across the entire spectrum of patients with coronary artery disease: a meta-analysis of randomized trials.

Reference: Ferrante G et al. J Am Coll Cardiol Intv. 2016; Epub ahead of print.

 

acceso_radial_finalRegardless the type of coronary syndrome, the transradial approach results in lower mortality and complications compared to the femoral.

Some studies (especially on chronic and stable patients) have seen contradicting results as regards the advantages of the transradial approach over the femoral, which is why this meta-analyzis of 24 studies was carried out, involving over 22,843 patients with PCI in the context of ACS

  • without ST elevation
  • with ST elevation
  • in stable patients

The transradial approach showed lower risk of all cause death (OR 0.71, CI 95% 0.58 to 0.87) and lower risk of combined cardiovascular events (OR 0.84; CI 95% 0.75 to 0.94) in the general population.

The transradial approach was also associated to lower major bleeding rate (OR 0.53; CI 95% 0.42 to 0.65) and lower major vascular complications rate (OR 0.23; CI 95% 0.16 to 0.34).

Other important data resulting from this work is that MI and stroke rates resulted similar for both vascular access sites.

When analyzing outcomes according to clinical presentation, stable patients are those who benefit most from reduced major bleeding. In the group of ACS patients, ST elevation MI patients saw the greatest benefit with transradial approach.

Lastly, the experienced centers obtained the highest benefits vs. femoral approach.

 

Conclusion

The transradial approach reduces mortality and combined events, and improves safety because of reduced bleeding and vascular complications, compared to the femoral access.

 

Editorial Comment

The benefit of the transradial approach seems out of question; however, a great randomized study would be useful to understand the mechanisms behind this advantage. Reduced major bleeding seems to be the main reason behind mortality decrease, though it may not be enough: there may be other, hidden mechanisms involved.

 

We value your opinion. You are more than welcome to leave your comments, thoughts, questions or any ideas here below.

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....